Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Diabetic Nephropathy

Diabetic Nephropathy

Definition Diabetic nephropathy is a chronic kidney complication that results from prolonged hyperglycemia.Prevalence It is the most common cause of chronic kidney disease (CKD) and end-stage renal disease (ESRD) worldwide, affecting up to half of individuals with diabetes.Pathophysiology • Sustained hyperglycemia triggers multiple hemodynamic and metabolic changes in the kidney. • Early in the disease, increased renal blood flow and glomerular hyperfiltration occur due to afferent arteriolar...

Pathophysiology of Diabetes

Pathophysiology of Diabetes

Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility, suggesting a...

Type I Diabetes II: Pathophysiology

Type I Diabetes II: Pathophysiology

Type 1 diabetes mellitus arises from an immune-mediated destruction of pancreatic β-cells, resulting in an absolute deficiency of insulin. This process develops in genetically susceptible individuals when autoimmunity, environmental exposures, and immunologic dysregulation converge to trigger a targeted attack on the insulin-producing cells of the pancreas. The β-cells are located within the islets of Langerhans and are essential for regulating blood glucose by facilitating cellular uptake of...

Type II Diabetes II: Pathophysiology

Type II Diabetes II: Pathophysiology

PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.

Diabetic Neuropathy

Diabetic Neuropathy

DefinitionDiabetic neuropathy is nerve damage caused by long-standing diabetes mellitus. It results directly from prolonged high blood sugar levels.PathophysiologyThe pathophysiology of diabetic neuropathy involves both metabolic and vascular disturbances triggered by chronic hyperglycemia.Metabolic injury: Elevated glucose levels activate the polyol pathway within nerve cells, leading to the accumulation of sorbitol and fructose. This increases oxidative stress, disrupts normal nerve...

Type II Diabetes I: Introduction

Type II Diabetes I: Introduction

Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder characterized by insulin resistance, in which target tissues such as the liver, muscle, and adipose tissue respond poorly to insulin. It is also associated with inadequate compensatory insulin secretion, where pancreatic β-cells fail to produce sufficient insulin. Together, these abnormalities lead to persistent hyperglycemia.EtiologyT2DM develops through a complex interaction of genetic predisposition and environmental or...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

HD-MUNet: integrating artificial intelligence and high-density electromyography for motor unit number estimation.

IEEE transactions on bio-medical engineering·2026

Same author

Comparison of 2 swept-source optical biometers: IOLMaster 700 vs. Revo FC 130.

Archivos de la Sociedad Espanola de Oftalmologia·2025

Same author

Good clinical practice recommendations for the management of gastroesophageal reflux disease. A Latin American expert review.

Revista de gastroenterologia de Mexico (English)·2025

Same author

Post-traumatic retinal siderosis, a case report.

Archivos de la Sociedad Espanola de Oftalmologia·2024

Same author

Effectiveness of handheld near infrared spectrometer for traceability of Angus steaks.

Food chemistry·2024

Same author

Progressive supranuclear palsy, a case report.

Archivos de la Sociedad Espanola de Oftalmologia·2024

Search research articles

Related Experiment Video

Updated: Jun 25, 2026

Comparative Proteomic Analysis of Whole Kidney, Medulla, and Cortical Tubules in Diabetic Pathogenesis of Kidney Injury in Mice

Comparative Proteomic Analysis of Whole Kidney, Medulla, and Cortical Tubules in Diabetic Pathogenesis of Kidney Injury in Mice

Published on: May 2, 2025

[Transcriptomics illustrate a deadly TRAIL to diabetic nephropathy].

A Benito-Martín¹, A C Ucero, B Santamaría

¹Fundación Jiménez Diaz, Madrid, Spain.

Nefrologia : Publicacion Oficial De La Sociedad Espanola Nefrologia

|February 26, 2009

Summary

Diabetic nephropathy patients may benefit from new therapies targeting inflammation and TNF-related apoptosis-inducing ligand (TRAIL), as these factors contribute to kidney cell death and disease progression.

Related Experiment Videos

Last Updated: Jun 25, 2026

Comparative Proteomic Analysis of Whole Kidney, Medulla, and Cortical Tubules in Diabetic Pathogenesis of Kidney Injury in Mice

Comparative Proteomic Analysis of Whole Kidney, Medulla, and Cortical Tubules in Diabetic Pathogenesis of Kidney Injury in Mice

Published on: May 2, 2025

Area of Science:

Nephrology
Molecular Biology
Genomics

Context:

Diabetic nephropathy is a leading cause of end-stage renal disease.
Current treatments targeting angiotensin II are insufficient for many patients.
High-throughput techniques offer potential for identifying novel therapeutic targets.

Purpose:

To identify novel mediators of renal cell death in diabetic nephropathy using renal biopsy transcriptomics.
To investigate the role of TNF-related apoptosis-inducing ligand (TRAIL) and osteoprotegerin in diabetic kidney disease.

Summary:

Transcriptomic analysis revealed dysregulation of cell death genes in diabetic kidneys.
TNF-related apoptosis-inducing ligand (TRAIL) and osteoprotegerin showed altered expression.
High glucose sensitized renal cells to TRAIL, while osteoprotegerin conferred protection.

Impact:

Suggests inflammation and TRAIL as potential therapeutic targets beyond glucose control.
Highlights the role of cell death pathways in diabetic nephropathy progression.
Provides a foundation for developing new treatment strategies for diabetic kidney disease.